Cost of Lung Cancer: A Methodological Review

Author： Molinier Laurent  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.7, 2006-01, pp. : 651-659

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cost of Dementia in Europe: A Review of the Evidence, and Methodological Considerations

By Jönsson Linus  

PharmacoEconomics, Vol. 27, Iss. 5, 2009-05 ,pp. : 391-403

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer: A Systematic Review

By Bongers Mathilda L.  

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 17-34

Adis International

Access to resources Recommend Favorite

Using QALYs in Cancer: A Review of the Methodological Limitations

By Garau Martina  

PharmacoEconomics, Vol. 29, Iss. 8, 2011-08 ,pp. : 673-685

Adis International

Access to resources Recommend Favorite

Cost effectiveness of lung cancer screening debated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 413, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

CT screening for lung cancer - cost effectiveness debated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 591, 2009-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite